Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2005
10/19/2005CN1682919A Acanthopanax root dripping pill and its preparing method
10/19/2005CN1682918A Tranquilizing wild jujube seed dripping pill and its preparing method
10/19/2005CN1682906A Chinese medicine preparation for treating neurosis
10/19/2005CN1682905A Process for preparing Chinese medicine compound dripping pill for treating headaches
10/19/2005CN1682850A Chinese medicine preparation for sobering up and liver protection
10/19/2005CN1682841A Table wine nutrition oral administration liquor for dispelling the effect of alcohol
10/19/2005CN1682833A Ginseng and schisandra fruit dripping pill and its preparing method
10/19/2005CN1682831A Ginseng and ophiopogon root dripping pill for nourishing Yin and promoting production of body fluid and its preparing method
10/19/2005CN1682824A Compound gastrodin injection and its preparation and use
10/19/2005CN1682806A Ginseng and fleece-flower root dripping pill and its preparing method
10/19/2005CN1682804A Oral administration dripping pill for nourishing heart to calm mind and its preparing method
10/19/2005CN1682802A Heart and brain health dripping pill for refreshing and strengthening brain and its preparing method
10/19/2005CN1682797A Active source preparation and its rpeparing method
10/19/2005CN1682788A Shutongfang for killing pain and its preparation and use
10/19/2005CN1682786A Adhesive plaster
10/19/2005CN1682775A Eucommia bark tablet and its preparing method
10/19/2005CN1682768A Naoxinshu solid preparation good for brain and heart
10/19/2005CN1682767A Pearl powder soft capsule
10/19/2005CN1682754A Ginseng-gaboderma lucidum tranquilizing dripping pill and its preparing method
10/19/2005CN1682750A Disodium adenosine triphosphate solid composition for injection and its preparing method
10/19/2005CN1682749A Flavone composition for sobering and liver protection and its use
10/19/2005CN1682735A Soft capsule containing flunarizine
10/19/2005CN1682734A Oral disintegration tablet of dihydroergotoxine and its derivatives and its preparing process
10/19/2005CN1682733A Anti-cancer analgetic preparation
10/19/2005CN1682723A Scopolamine hydrobromide dry powder inhalant for nose and preparing method
10/19/2005CN1682719A Enteric soluble coating slow releasing tablet containing huperzine A and preparing method
10/19/2005CN1682704A Levodopa nano preparation and its preparing method
10/19/2005CN1223678C Pseudozoogloea particle adjuvant preparation and application
10/19/2005CN1223591C Piperazine oxime derivatives having Nk-1 receptor antagonistic activity
10/19/2005CN1223353C Yin-nourishing and heat-clearing, mental anxiety easing preparation
10/19/2005CN1223351C Use of low-molecular-weight heparins for preventing and treating cerebral edemas
10/19/2005CN1223349C Drug combination for treatment of depression and related disorders comprising mirtazapine
10/19/2005CN1223348C N-(aryloxy group alkyl) heteroaromatic guadine and heteroaromatic guazine used as medicines
10/19/2005CN1223346C Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
10/19/2005CN1223340C Electrospun pharmaceutical compositions
10/18/2005US6956060 Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
10/18/2005US6956052 treatment of cancer and inflammation-associated disorders, such as arthritis; for example,1-[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide
10/18/2005US6956050 Imidazole compounds as anti-inflammatory and analgesic agents
10/18/2005US6956045 Anticancer agents; antiallergens; immunology diseases; antiinflamamtory agents
10/18/2005US6956042 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
10/18/2005US6956041 Protein kinase inhibitors
10/18/2005US6956037 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/18/2005US6956033 3,4-dihydroisoquinoline derivative compound and a pharmaceutical agent comprising it as active ingredient
10/18/2005US6956028 Administering pyrimidine nucleotide precursor where respiratory chain dysfunction is caused by mutation, deletion, or rearrangement of mitochondrial DNA, cytotoxic cancer chemotherapy agents, aging
10/18/2005US6955815 Combinations for the treatment of inflammatory disorders
10/18/2005US6955810 Method for the treatment of inflammatory disorders
10/18/2005CA2340138C 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/18/2005CA2339273C Branched alkyl pyrrolidine-3-carboxylic acids
10/18/2005CA2334702C Pharmaceutical compositions and uses for androst-5-ene-3.beta.,17.beta.-diol
10/18/2005CA2240728C Kappa agonist compounds and pharmaceutical formulations thereof
10/18/2005CA2148928C Pharmacologically active pyridine derivatives and processes for the preparation thereof
10/18/2005CA2132544C Angiotensin ii antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy
10/18/2005CA2125730C Novel sulfonylamino pyrimidines
10/13/2005WO2005099727A1 Drug
10/13/2005WO2005095633A1 A cell culture system for modelling serum amyloid a amyloidogenesis and identifying amyloid modulating compounds
10/13/2005WO2005095604A1 Rf rp transgenic animal
10/13/2005WO2005095600A1 Heparin-binding protein having heparan sulfate sugar chain attached thereto, process for producing the same and medicinal composition containing the same
10/13/2005WO2005095587A1 Process for producing somatic stem cell differentiated from embryonic stem cell and use of the same
10/13/2005WO2005095452A1 Calcium ion leakage inhibitors
10/13/2005WO2005095443A1 Drug delivery system using peptide modification
10/13/2005WO2005095381A1 Dipeptidyl peptidase inhibitors
10/13/2005WO2005095375A1 Extract of sophora flavescens flavonoids and uses thereof
10/13/2005WO2005095360A1 Neurologically-active compounds
10/13/2005WO2005094881A1 Antibody drug
10/13/2005WO2005094858A1 Antidiabetic composition
10/13/2005WO2005094855A1 Pharmaceutical composition containing salix spec. (willow) extract for the treatment of depressions, sleeping disorders, and states of anxiety and/or restlessness
10/13/2005WO2005094849A1 Functional food for ameliorating engogenous melatonin secretion rhythm and functional food for ameliorating circadian rhythm
10/13/2005WO2005094846A1 Remedy for prion disease and method of producing the same
10/13/2005WO2005094831A1 Sustained-release tablet formulation
10/13/2005WO2005094821A1 A medical composition for increasing the medicine safety
10/13/2005WO2005094805A1 Imine derivative and amide derivative
10/13/2005WO2005081613A3 Pharmaceutical compositions of peptides secreted by the venom glands of snakes
10/13/2005WO2002014467A9 Cng2b: a putative human cyclic nucleotide-gated ion channel
10/13/2005US20050228337 Transcutaneous infusion of carbon dioxide for local relief of pain and other ailments
10/13/2005US20050228170 B7-like molecules and uses thereof
10/13/2005US20050228169 Polypeptide binding to human syntaxin 1a
10/13/2005US20050228055 Substituted nitrobenzene derivatives as pharmaceutical and other uses athereof
10/13/2005US20050228043 Preparation of trans-fused 3,3a,8,12b-tetrahydro-2H-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives
10/13/2005US20050228036 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
10/13/2005US20050228025 Substituted oxindole derivatives as tyrosine kinase inhibitors
10/13/2005US20050228024 Pharmaceutical compositions comprising a benzofuran derivative and their use for the treatment of attention deficit/hyperactivity disorder
10/13/2005US20050228022 blocking voltage-sensitive sodium channels of neurons in a mammal comprising administering 1-benzyl-2-imino-3-(2-hydroxy-3-phenoxypropyl)benzimidazole; analgesics; neuroprotectants; anticonvulsants
10/13/2005US20050228020 Beta secretase inhibitors
10/13/2005US20050228018 Chemical compounds
10/13/2005US20050228011 use of carboxy-functional benzofurans or benzothiophenes to treat tumor growth, metastasis, osteoporosis, restenosis, inflammation, macular degeneration, diabetic retinopathy, rheumatoid arthritis, and sickle cell anemia; greater bioavailability or fewer side-effects
10/13/2005US20050228010 Antidepressant azahetorocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene
10/13/2005US20050228005 Protein kinase inhibitors and uses thereof
10/13/2005US20050227997 Selective inhibition of aggrecanase in osteoarthritis treatment
10/13/2005US20050227995 Phenyl sulfoxides and phenyl sulfones
10/13/2005US20050227993 Novel analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders
10/13/2005US20050227991 Containing a piperazine ring, e.g., N'-(4-{4-[5-(1,2-dithiolan-3-yl)pentanoyl]-1-piperazinyl)phenyl)-2-thiophenecarboximidamide and intermediates for preparing them; useful for inhibiting NO synthase and regenerating antioxidants
10/13/2005US20050227988 compounds capable of inhibiting, modulating and/or regulating signal transduction of both receptor-type and non-receptor type tyrosine kinases; gliomas, meningomas, cancers, Hodgkin's disease, retinal vascularization; core structure that comprises a benzazocine moiety
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227984 Drugs for improving the prognosis of brain injury and a method of screening the same
10/13/2005US20050227979 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety
10/13/2005US20050227974 Aminoalkyl-substituted aryl compounds and their use as sodium channel blockers
10/13/2005US20050227972 treating disorders of the cardiovascular system; adenosine receptor agonists/antagonists
10/13/2005US20050227957 Therapy for oxidation stresses; complex of drug and enzyme mimetics; lipophilic cation moiety covalently bonded to glutathione peroxidase mimetic moiety is selected from the group consisting of: benzisoselenazolones, diaryl diselenides and diaryl selenides
10/13/2005US20050227951 Verification of translation
10/13/2005US20050227948 Hif hydroxylase inhibitors
1 ... 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 ... 1833